BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
762 results:

  • 1. Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study.
    Nyboe Andersen N; Wildt S; Iversen AT; Poulsen G; Jess T; Munck LK; Borup C
    BMJ Open Gastroenterol; 2024 Apr; 11(1):. PubMed ID: 38688717
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in colorectal Carcinoma Cells.
    Jacksi M; Schad E; Tantos A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. B7-H3 Expression in Breast cancer and Brain Metastasis.
    Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence?
    Stucchi E; Bartolini M; Airoldi M; Fazio R; Daprà V; Mondello G; Prete MG; Puccini A; Santoro A
    Expert Opin Pharmacother; 2024 Mar; 25(4):371-382. PubMed ID: 38568032
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
    Lin J; Zhong W; Lyu Z; Peng J; Rong Y; Zeng K; Lai J; Wu D; Wang J; Li Y; Zheng J; Zhang J; Pan Z
    Cancer Lett; 2024 May; 589():216825. PubMed ID: 38548218
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling.
    Chomiak AA; Tiedemann RL; Liu Y; Kong X; Cui Y; Wiseman AK; Thurlow KE; Cornett EM; Topper MJ; Baylin SB; Rothbart SB
    Sci Adv; 2024 Mar; 10(13):eadk4423. PubMed ID: 38536911
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.
    Li CMY; Briggs MT; Lee YR; Tin T; Young C; Pierides J; Kaur G; Drew P; Maddern GJ; Hoffmann P; Klingler-Hoffmann M; Fenix K
    Clin Exp Med; 2024 Mar; 24(1):53. PubMed ID: 38492056
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Management of acute and chronic pelvic sepsis after total mesorectal excision for rectal cancer-a 10-year experience of a national referral centre.
    Sharabiany S; Joosten JJ; Musters GD; Talboom K; Tanis PJ; Bemelman WA; Hompes R
    Colorectal Dis; 2024 Apr; 26(4):650-659. PubMed ID: 38418896
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Synergic actions of botulinum neurotoxin A and oxaliplatin on colorectal tumour cell death through the upregulation of TRPM2 channel-mediated oxidative stress.
    Demir S; Duman İ; Nazıroğlu M
    Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13844. PubMed ID: 38350599
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.
    McCarthy G; Young K; Madin-Warburton M; Mantaian T; Brook E; Metcalfe K; Mikelson J; Xu R; Seyla-Hammer C; Aguiar-Ibáñez R; Amonkar M
    J Med Econ; 2024; 27(1):279-291. PubMed ID: 38293714
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors.
    Wang M; Lv X; Wang Y; Li Y; Li H; Shen Z; Zhao L
    Cancer Med; 2024 Feb; 13(3):e6935. PubMed ID: 38230764
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cationic micelle delivery of a multi-epitope vaccine candidate derived from tumor-associated antigens, causing regression in established CT26 colorectal tumors in mice.
    Sabzehei F; Taromchi AH; Ramazani A; Nedaei K; Feizi A; Arsang-Jang S; Danafar H
    J Biomed Mater Res A; 2024 May; 112(5):733-742. PubMed ID: 38088136
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Soluble B7-H3 in colorectal cancer.
    Kovaleva OV; Gratchev AN; Sokolov NY; Maslennikov VV; Kuzmin YB; Gershtein ES; Alferov AA; Mamedli ZZ; Stilidi IS; Kushlinskii NE
    Bull Exp Biol Med; 2023 Nov; 176(1):87-90. PubMed ID: 38085395
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer.
    Zhang H; Zhu M; Zhao A; Shi T; Xi Q
    Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189031. PubMed ID: 38036107
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges.
    Chen X; Huang Y; Chen B; Liu H; Cai Y; Yang Y
    Eur J Med Chem; 2024 Jan; 263():115947. PubMed ID: 37976704
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. NF-κB downstream miR-1262 disturbs colon cancer cell malignant behaviors by targeting fgfr1.
    Zhang W; Huang Z; Xiao Z; Wang H; Liao Q; Deng Z; Wu D; Wang J; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1819-1832. PubMed ID: 37867436
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mild-Photothermal Effect Induced High Efficiency Ferroptosis-Boosted-Cuproptosis Based on Cu
    Chen W; Xie W; Gao Z; Lin C; Tan M; Zhang Y; Hou Z
    Adv Sci (Weinh); 2023 Nov; 10(33):e2303694. PubMed ID: 37822154
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genome-Wide Association and Two-Sample Mendelian Randomization Analyses of Plasma Ghrelin and Gastrointestinal cancer Risk.
    Larsson SC; Höijer J; Sun J; Li X; Burgess S; Michaëlsson K
    Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1771-1776. PubMed ID: 37791980
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. LINC00922 decoys SIRT3 to facilitate the metastasis of colorectal cancer through up-regulation the H3K27 crotonylation of ETS1 promoter.
    Liao M; Sun X; Zheng W; Wu M; Wang Y; Yao J; Ma Y; Gao S; Pei D
    Mol Cancer; 2023 Oct; 22(1):163. PubMed ID: 37789393
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention.
    Varghese E; Samuel SM; Brockmueller A; Shakibaei M; Kubatka P; Büsselberg D
    Cancer Metastasis Rev; 2024 Mar; 43(1):115-133. PubMed ID: 37768439
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 39.